Related Experiment Videos
Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors
Abstract:
We demonstrate here consistent point mutations of the c-raf-1 proto-oncogene, within a small region of the kinase domain, in a mouse model for chemical tumor induction. This is the first demonstration of point mutated raf genes in vivo, and the first isolation of activating in vivo point mutations in the kinase domain of a proto-oncogene. The specific region where these mutations are clustered also has biological significance. This is precisely the region where 5/5 independently generated monoclonal antibodies raised against Raf-1 map to [29], and predictions based upon the crystal structure of A kinase identify this as the substrate pocket. The tumors examined show a selective specificity for Raf-1 mutations in that another family of genes, the ras proto-oncogenes which are frequently activated by point mutation in both animal and human tumors [15-21,26], is not involved. Our consistent finding of Raf-1 mutations in a mouse tumor model also has consequences for further evaluation of the role of Raf-1 in human tumor development, as it emphasizes the need to examine c-raf-1 at the sequence level. In fact preliminary screening of human lung tumors indicates point mutations at amino acid 533 (John Lyons, personal communication). Finally, the cumulative data on the critical role of Raf-1 in signal transduction and the occurrence of oncogenic Raf-1 in tumors [32-41] highlight this enzyme as an attractive target for development of novel anticancer regimens.
Insights
Consistent point mutations in the c-raf-1 proto-oncogene kinase domain were found in vivo in a mouse tumor model. This discovery highlights Raf-1 as a potential target for novel anticancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Proto-oncogenes, such as c-raf-1, play crucial roles in cell signaling and can become oncogenic when mutated.
- Activating mutations in proto-oncogenes are frequently observed in various human and animal tumors.
- The kinase domain of Raf-1 is critical for its function and is a region of interest for oncogenic alterations.
Purpose of the Study:
- To investigate the presence and characteristics of c-raf-1 mutations in a mouse model of chemically induced tumors.
- To determine if activating point mutations in the kinase domain of c-raf-1 occur in vivo.
- To assess the specificity of mutations for c-raf-1 over other proto-oncogenes like ras.
Main Methods:
- Utilized a mouse model for chemical tumor induction.
- Performed genetic analysis to identify point mutations in the c-raf-1 proto-oncogene within the kinase domain.
- Examined tumor samples for mutations in c-raf-1 and related proto-oncogenes (ras).
Main Results:
- Demonstrated consistent point mutations in the c-raf-1 proto-oncogene kinase domain in vivo.
- This is the first report of in vivo point mutations in the raf gene and activating mutations in the kinase domain of a proto-oncogene.
- Observed a selective specificity for Raf-1 mutations, with ras proto-oncogenes not being involved in the examined tumors.
- Preliminary screening of human lung tumors indicated similar mutations at amino acid 533.
Conclusions:
- Consistent in vivo mutations in the c-raf-1 kinase domain suggest its critical role in chemical carcinogenesis.
- The findings emphasize the need to examine c-raf-1 at the sequence level for understanding human tumor development.
- Oncogenic Raf-1 mutations highlight this enzyme as a promising target for developing new anticancer treatments.